Negative regulation of synapse organization

pathway activity — cross-omics
GO:1905809Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Negative regulation of synapse organization pathway is significantly associated with the RNA expression of multiple genes, with the LUAD cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are PTPN13, ADAMDEC1, and FGD6, each associated with the pathway in up to 9 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Negative regulation of synapse organization activity versus PTPN13 in LUAD (Pearson r = 0.64).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
LUADPTPN13 →+1.515+0.605<.001<.00139
HNSCADAMDEC1 →-1.119-0.309<.001.00235
PDACFGD6 →+0.558+0.180<.001.00135
LUADCRTAP →+0.254+0.366.005.00726
LUADSORCS2 →+0.903+0.523<.001<.00135
HNSCCEP128 →-0.678-0.438<.001.00234
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:1905809 vs PTPN13 — LUAD

Per-sample scatter of Negative regulation of synapse organization activity vs PTPN13 in LUAD.

Explore this scatter interactively →

Exploration